INTRODUCTION
============

The effects of air pollution on health have been actively studied, and its associations with the development and aggravation of cardiovascular disease, respiratory disease, and cerebrovascular disease have been explored through many studies. According to a World Health Organization report, diabetes mellitus (DM) has reached global epidemic status, and the worldwide prevalence of DM is estimated at about 8.5% (422 million). Fifteen million people die each year due to DM, which is the eighth most common cause of death. In spite of the great concern about the health effects of air pollution and the high disease burden of DM, few studies have investigated the impact of air pollution on metabolic disease, and furthermore, the results have been inconsistent among those studies that have been performed \[[@b1-jpmph-51-6-265]\].

A large-scale cohort study conducted in Europe \[[@b2-jpmph-51-6-265]\] showed that both nitrogen dioxide (NO~2~) and ozone (O~3~) were significantly associated with the incidence and prevalence of DM. Another study \[[@b3-jpmph-51-6-265]\] also suggested that air pollution appears to increase the risk of acute complications of DM that lead to hospitalization.

Many experimental studies have shown that possible pathways mediating the effects of air pollution on DM may include endothelial dysfunction, exaggerated sympathetic nervous system response, changes in the immune response in visceral adipose tissue, alterations in mitochondria and brown adipocytes, and endoplasmic reticulum stress resulting in dysregulation of insulin signaling, insulin sensitivity, and glucose metabolism \[[@b4-jpmph-51-6-265]\]. Because some of these pathways are significantly associated with exposure to air pollutants, it is possible that high exposure to air pollutants might increase the incidence of DM. One of the most notable complications of DM is diabetic coma caused by diabetic ketoacidosis (DKA) \[[@b5-jpmph-51-6-265]\] and hyperosmolar hyperglycemic state (HHS). These two serious acute complications represent an extreme hyperglycemic condition with coma, and if not treated properly, the mortality rate of this condition reaches 10-20% \[[@b6-jpmph-51-6-265]\]. Diabetic coma can occur if the balance of fasting blood glucose---which is typically maintained by a combination of the patient's usual diet, physical activity, and hypoglycemic drugs---is broken by changes in the external environment.

Considering the inflammatory and oxidative responses after exposure to air pollutants, it is possible that among patients with DM, the incidence of diabetic coma might be associated with high exposure to air pollutants. However, few studies have addressed this issue. Thus, in this study, we investigated the association between ambient air pollution and the risk of emergency department (ED) visits for diabetic coma using national representative emergency care utilization data in the South Korea (hereafter Korea).

METHODS
=======

Study Population
----------------

All subjects who visited an ED in Seoul, Korea from January 1, 2005, to December 31, 2009, were included in this study. The participants were enrolled based on health claims data obtained from the Health Insurance Review and Assessment Service (HIRA), which is part of the National Health Insurance (NHI) program of the Korea. Health claims data includes age, sex, diagnosis code (International Classification of Diseases, 10th Revision, ICD-10), and data about the hospital visit (ED, outpatient clinic, or admission), and regional code of the hospital.

Diabetic coma was defined according to the ICD-10: E100, E110, E120, E130, and E140. E100 denotes type 1 DM with coma; E110, type 2 DM with coma; E120, malnutrition-related DM with coma; E130, other specified DM with coma; and E140, unspecified DM with coma. To identify pre-existing illnesses, we used the prior medical service utilization history of each subject. We defined pre-existing illness as a disease that had been reported on during at least 2 outpatient visits, or more than 1 hospitalization for the disease during the 3 years prior to the ED visit. The subjects were classified into 4 groups according to pre-existing illnesses: cardiovascular disease (hypertensive disease \[ICD-10: I10, I11, I12, I13, I14, I15\], ischemic heart disease \[ICD-10: I20, I21, I22, I23, I24, I25\]), chronic obstructive pulmonary diseases (COPD; ICD-10: J40, J41, J42, J43, J44), and asthma (ICD-10: J45, J46).

The unit of analysis was daily ED visits for diabetic coma. All observations of ED visits for diabetic coma during the study period were included, allowing duplication of participants.

Air Pollutants and Meteorological Data
--------------------------------------

Particulate matter less than 10 μm in aerodynamic diameter (PM~10~), sulfur dioxide (SO~2~), NO~2~, O~3~, and carbon monoxide (CO) were considered to be ambient air pollutants in this study. This data was collected by the National Institute of Environmental Research under the Ministry of Environment of Korea from January 1, 2005, to December 31, 2009. Air pollutants were measured at 27 stations in Seoul, which were distributed to be representative of 25 districts in Seoul. The daily mean value was calculated using the hourly measured concentration of each air pollutant. For O~3~, the 8-hour average concentration was used. The methods of measurement were as follows: beta-ray absorption method (PM~10~, μg/m^3^), chemiluminescent method (NO~2~, parts per billion \[ppb\]), pulsed ultraviolet (UV) fluorescence method (SO~2~, ppb), UV photometric method (O~3~, ppb), and non-dispersive infrared method (CO, parts per million). The meteorological data including temperature (°C) and relative humidity (%) were obtained from the Korea Meteorological Administration.

Study Design and Statistical Analysis
-------------------------------------

To explore the association between daily ED visits for diabetic coma and short-term exposure to air pollution, we applied a time-series design that has been generalized to use distributed-lag non-linear models (DLNMs) \[[@b7-jpmph-51-6-265]\]. We used a generalized additive model with quasi-Poisson regression because this model permits non-parametric adjustments to non-linear confounding effects of the season, trend, and weather variables in a time-series study of air pollution \[[@b8-jpmph-51-6-265]\].

A general model for illustrating the time series of outcomes (the number of ED visits for diabetic coma) is as below:

Log \[E(Y)\]=*α*+*cb~1~* ambient air pollution+*cb~2~* (temperature, *df*=6)+*β~1~* day of week+*β~2~* holiday+s (relative humidity, *df*=3)+offset (log\[population of the year\])

E(Y): estimated daily ED visits for diabetic coma

s( ): the natural cubic spline for the non-linear variable

*cb~1~*: cross-basis function illustrating the relationship of a 2-dimensional linear function model for air pollutants and for 3 strata for lags (lag 0-1, lag 2, lag 3)

*cb~2~*: cross-basis function modelling the natural cubic spline function with 6 df per year for the mean temperature and for 2 strata for lags (lag 0-1, lag 2-3)

*df*: the degree of freedom for the prediction space and the lag space

*α*: the intercept

*β*: the parameter vector that predicts the effect of environmental factors

offset: correction of the number of events for an estimate of population size

Daily average relative humidity was included as a natural cubic spline function with 3 degrees of freedom (*df*) per year to control for the potential non-linear confounding effects of weather conditions. The day of the week and public holidays were also added into the models as dummy variables to adjust for the effects of long-term trends.

To evaluate the lag effect of air pollutants on diabetic coma prior to ED visits, DLNMs were used \[[@b7-jpmph-51-6-265]\]. A DLNM is defined through a cross-basis function, which is composed of the basis function for the 2-dimensional exposure, as well as lag, and so allows the simultaneous estimation of a non-linear exposure-response association and delayed effects across lags. In this study, the exposure-response function of each air pollutant was assumed to be linear, and the lag structure was assumed to be constant within each stratum of the lag day, which is known as the lag-stratified distributed-lag model. We also included a cross-basis function of the daily mean temperature, modelling the relationship using a natural cubic spline with 6 *df* per year and the lag structure defined by 3 strata (lag 0-1, lag 2, lag 3). Because of the linear relationship of air pollutants, they are actually distributed-lag linear models, even if the distributed lag function of the temperature is included as a non-linear term \[[@b9-jpmph-51-6-265]\]. The *df* for both relative humidity and daily mean temperature were determined empirically. In a sensitivity analysis, the direction of the relationship and the strength of the association did not change ([Table S1](#SD1-jpmph-51-6-265){ref-type="supplementary-material"}).

Final estimates are presented as the relative risks (RRs) (with 95% confidence intervals \[CIs\]) of daily visits for diabetic coma for an interquartile range (IQR) increment in each air pollutant. All analyses were performed with the R version 3.3.2 (<https://cran.r-project.org/bin/windows/base/old/3.3.2/>) using the *mgcv* and *dlnm* packages.

RESULTS
=======

A total of 3532 cases of ED visits. for diabetic coma occurred during the study period. Of these, 3527 events were included in the study, after excluding 5 cases without information on the patient's age and sex ([Table 1](#t1-jpmph-51-6-265){ref-type="table"}). The average age of the study subjects was 57.66 (standard deviation \[SD\], 17.44); 50.7% were male. [Table 2](#t2-jpmph-51-6-265){ref-type="table"} summarizes the annual average concentration of air pollutants during the study.

In both single- and cumulative-response models, the risk of ED visits for diabetic coma was significantly associated with NO~2~ concentration at single lag 1 (RR, 1.125; 95% CI, 1.039 to 1.219) and at cumulative lags 0-1 (RR, 1.120; 95% CI, 1.028 to 1.219) and lag 0-3 (RR, 1.092; 95% CI, 1.005 to 1.186) ([Table 3](#t3-jpmph-51-6-265){ref-type="table"}).

For an IQR increase at lag 0-3, NO~2~ was positively associated with ED visits for diabetic coma ([Figure 1](#f1-jpmph-51-6-265){ref-type="fig"}). The RR for annual average NO~2~ was 1.092 (95% CI, 1.005 to 1.186) at lag 0-3. In the subgroup analysis by sex, the RR of NO2 for females at cumulative lag 0-3 (1.149; 95% CI, 1.022 to 1.291) was statistically significant ([Figure 1](#f1-jpmph-51-6-265){ref-type="fig"}). The RR of NO~2~ for males was not significant at cumulative lag 0-3, but was significant at single lag 1 (1.136; 95% CI, 1.015 to 1.271) ([Table 4](#t4-jpmph-51-6-265){ref-type="table"}).

In the subgroup analysis by age group, the RRs for NO~2~ were statistically significant in people aged 60 years or over at single lag 1 (RR, 1.108; 95% CI, 1.009 to 1.218) and cumulative lag 0-1 (RR, 1.112; 95% CI, 1.006 to 1.230) ([Table 4](#t4-jpmph-51-6-265){ref-type="table"}).

After stratifying the underlying diseases, for individuals with a history of hypertensive disease, a positive association was found for an IQR increment of NO~2~ at cumulative lag 0-2 (RR, 1.168; 95% CI, 1.014 to 1.346) and for CO (RR, 1.130; 95% CI, 1.026 to 1.243) at cumulative lag 0-3 ([Figure 1](#f1-jpmph-51-6-265){ref-type="fig"} and [Table 3](#t3-jpmph-51-6-265){ref-type="table"}). For individuals without any history of hypertensive disease, ischemic heart disease, asthma, or COPD, the RR for NO~2~ was 1.164 (95% CI, 1.039 to 1.305) at single lag 1 and 1.145 (95% CI, 1.014 to 1.293) at cumulative lag 0-1.

In the seasonal analysis, the association was sustained in sp-ring at cumulative lag 0-2 (RR, 1.174; 95% CI, 1.001 to 1.377) and in autumn at single lag 1 (RR, 1.231; 95% CI, 1.029 to 1.473) and cumulative lag 0-2 (RR, 1.201; 95% CI, 1.020 to 1.414) and lag 0-3 (RR, 1.190; 95% CI, 1.015 to 1.395) ([Figure 1](#f1-jpmph-51-6-265){ref-type="fig"} and [Table S2](#SD2-jpmph-51-6-265){ref-type="supplementary-material"}).

DISCUSSION
==========

In our study, IQR increases in the concentration of NO~2~ were positively associated with ED visits for diabetic coma. The association was statistically significant at single lag 1 and cumulative lags 0-1 and 0-3. Other pollutants were partially associated with ED visits for diabetic coma, but not sustained for all lags. For example, the RR for CO at lag 1 was 1.106 (95% CI, 1.026 to 1.194), and at cumulative lag 0-1 it was 1.085 (95% CI, 1.011 to 1.166). However, this relationship was not found at other lags.

We found some suggestive effect modifiers. In females and those aged over 60, the RR at cumulative lag 0-3 was higher than the total average RR. Comorbid hypertensive disease, ischemic heart disease, COPD, or asthma was not associated with increased ED visits for diabetic coma.

This finding was consistent with previous studies. There have been relatively few studies that have investigated the association between the acute effects of air pollution and diabetic coma compared with the number of epidemiologic studies of the relationship between air pollution and the prevalence or incidence of DM. A time-series study was done in Chile in 2012 \[[@b3-jpmph-51-6-265]\] to investigate the relationship between daily air pollution concentration and daily hospitalizations of patients with DM for coma and ketoacidosis. There was a positive association, and the RR for an IQR (27.95) increment of NO~2~ was 1.12 (1.05, 1.20) (IQR, 27.94). These results were consistent with the findings of our study.

In a study conducted to evaluate the relationship between chemical components of air pollution and emergency hospital admissions for type 2 DM \[[@b10-jpmph-51-6-265]\], short-term exposure to PM~10~ components such as nitrate and elemental carbon increased the risk of acute complications or exacerbation of symptoms of DM. Considering that the nitrate radical has been observed as a result of the flash photolysis of NO~2~ \[[@b11-jpmph-51-6-265]\], this finding is compatible with the results of our study.

In a series of studies, the effects of air pollution on the prevalence or incidence of DM have shown relatively consistent results. In a large cohort study involving 51 818 subjects followed for 9.7 years that was performed in Denmark \[[@b12-jpmph-51-6-265]\], mean NO2 levels were statistically significantly associated with confirmed cases of DM (RR, 1.04; 95% CI,1.00 to 1.08). A meta-analysis \[[@b13-jpmph-51-6-265]\] including 10 studies assessed the effect of air pollutants on the occurrence of diabetes. The overall effect on DM incidence was significant for NO~2~ (adjusted hazard ratio, 1.13; 95% CI, 1.01 to 1.22).

Given that DM is a disease characterized by elevated blood glucose levels, the impact of air pollution on DM can be quantified by serum glucose increments. A longitudinal study that included 131 882 subjects \[[@b14-jpmph-51-6-265]\] revealed that serum glucose increased among subjects with normal glucose. Impaired fasting glucose and DM were associated with a 6.36-ppb increase of NO~2~ at lag 1, 2, and 3 (0.40% \[0.31, 0.50\], 0.56% \[0.40, 0.71\], and 1.08% \[0.86, 1.29\], respectively).

Insulin resistance mediated by air pollution has been hypothesized as the underlying physiological mechanism of the relationship between air pollution and acute DM \[[@b15-jpmph-51-6-265]\]. In a cross-sectional study \[[@b16-jpmph-51-6-265]\], a 1-ppb increment in the annual average of particulate matter less than 2.5 μm aerodynamic diameter (PM~2.5~), elevated fasting glucose of 0.07 mmol/L (*p*=0.005) and insulin resistance assessed by the homeostatic model increased by 4.58. But was borderline significant (*p*=0.07).

In our study, being female was a suggestive effect modifier for the association between air pollutants and diabetic coma. Several studies have reported a stronger effect in females than males \[[@b12-jpmph-51-6-265],[@b17-jpmph-51-6-265]-[@b19-jpmph-51-6-265]\]. In pooled analysis \[[@b4-jpmph-51-6-265]\] of these studies, the RR for males was 1.04 (95% CI, 0.93 to 1.17), which was not statistically significant, whereas the RR for females was 1.14 (95% CI, 1.03 to 1.26). There are some hypotheses that may explain this effect. One possible explanation is, of course, that females are more susceptible to air pollution. The other possibility is exposure measurement error. Males in the Korea tend to engage in more physical activity and more often commute or engage in other activities far from home than female do. Exposure to air pollutant is calculated based on residence address, so long commute and frequent activities might cause an exposure measurement error. There are some possible explanations for the seasonal interaction, including the diurnal temperature range, which is an important meteorological variable related to climate change and urbanization. A previous study showed that a greater diurnal temperature range is related to an increase in non-traumatic, cardiovascular, and cardiorespiratory mortality \[[@b20-jpmph-51-6-265]\].

The mechanism for the relationship between exposure to air pollution and DM is not known, but hypotheses include an inflammatory response or oxidative stress response \[[@b21-jpmph-51-6-265]\]. There is evidence that exposure to PM2.5 appears to be strongly associated with systemic inflammatory markers including white cell count \[[@b22-jpmph-51-6-265]\], interleukin-6 (IL-6), fibrinogen \[[@b23-jpmph-51-6-265]\], and C-reactive protein \[[@b18-jpmph-51-6-265]\]. An air pollution-induced inflammatory response in the lungs mediates alterations to autonomic balance, and this may exacerbate systemic insulin resistance via overactivity of the sympathetic nervous system \[[@b24-jpmph-51-6-265],[@b25-jpmph-51-6-265]\]. Endothelial dysfunction also plays a role in disruption of glucose homeostasis \[[@b26-jpmph-51-6-265]\] via insulin resistance. Co-exposure to multiple air pollutants (SO~2~, NO~2~, and PM~2.5~) caused endothelial dysfunction by elevating endothelin-1 expression \[[@b27-jpmph-51-6-265]\] and repressing the endothelial nitric oxide synthase level, as well as stimulating the inflammatory response by increasing the levels of cyclooxygenase 2, inducible nitric oxide synthase, tumor necrosis factor-a, and IL-6.

These relationships can explain the long-term effects of air pollution on the development of DM, but they cannot fully explain the complications caused by acute exacerbation of DM. Another explanation is the effect of counter-regulatory hormones. The most important mechanism in the development of diabetic coma due to DKA or HHS is hyperglycemia, and the osmotic diuretic effect caused by hyperglycemia exacerbates hyperosmolar hyperglycemia itself \[[@b28-jpmph-51-6-265]\]. In this mechanism, insulin and glucagon, the two hormones that regulate serum glucose, play a key role. Absolute or relative insulin deficiency, glucagon oversecretion, and insulin-antagonistic counter-regulatory hormones such as catecholamine \[[@b29-jpmph-51-6-265]\] and cortisol all contribute to the development of diabetic coma. Secretion of catecholamine by the activated autonomic system can induce hyperglycemia in susceptible individuals with predisposing factors \[[@b30-jpmph-51-6-265]\].

The predisposing or precipitating factors for DKA and HHS are inadequate insulin treatment or non-compliance, as well as acute illnesses which induce relative insulin deficiency including infection, cerebrovascular accident, myocardial infarction, and endocrine disorders. In our study, old age was suggested as a possible effect modifier. Old age \[[@b31-jpmph-51-6-265]\] and low socioeconomic status \[[@b32-jpmph-51-6-265]\] interfere with regular health screenings and periodic insulin dose adjustments. This may contribute to diabetic coma due to increased serum glucose caused by air pollution in individuals who already had unrecognized hyperglycemia.

The present study has several strengths. First, to the best of our knowledge, this is the first study to establish a correlation between air pollution and diabetic coma in Korea. Second, by using the HIRA database, almost the entire population of Seoul, Korea was included. The HIRA database includes all residents of the Korea because the NHI covers the whole population as a compulsory social insurance system and HIRA uses the national claim database of the NHI for quality assessment.

Third, we applied an advanced statistical approach: distributed non-linear lag models that flexibly account for the delayed and non-linear effects of air pollutants and temperature and provide simultaneous estimates of the lag-specific risks and cumulative effect.

Nevertheless, our study has some potential limitations. First, considering that DKA is characteristically associated with type 1 DM \[[@b33-jpmph-51-6-265]\], whereas HHS most commonly develops with type 2 DM, it could be more appropriate to analyze type 1 DM with coma (E10.0) and type 2 DM with coma (E11.0) separately. However, even though DKA is more common in younger patients with type 1 DM, it can also occur with type 2 DM. DKA and HHS are part of a spectrum, representing the metabolic consequences of insulin deficiency, glucagon excess, and counter-regulatory hormonal responses to stressful triggers in patients with DM \[[@b34-jpmph-51-6-265]\].

Second, we used the average concentrations of 27 monitoring sites in Seoul rather than personal measures for air pollution exposures because we were not able to obtain data on individual exposure to air pollutants. However, this measurement error may bias our results toward the null, underestimating the RRs \[[@b35-jpmph-51-6-265]\].

Third, potential confounding from individual-level risk factors for diabetic coma, including inadequate application of treatments such as oral hypoglycemic drugs or insulin, as well as poor dietary patterns, lack of physical activity, and poor medical compliance, could not be fully excluded due to the inherent characteristics of an ecological study. Nevertheless, the time-series design we applied in this study assesses the short-term effect of air pollutants and its unit of analysis is time. Thus, the temporal nature of a time-series design can avoid some concerns about personal confounders that do not change over short durations of time \[[@b36-jpmph-51-6-265]\].

In this study, exposure to ambient air pollutants was correlated with ED visits for diabetic coma especially in females and those 60 and older. These findings may help establish specific recommendations or guidelines for high-risk individuals by identifying susceptible populations to air pollution.
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![Relative risks (RRs) and 95% confidence intervals (Cls) for an interquartile range (IQR) increment of each air pollutant. (A) Total RRs and 95% Cls for an IQR increment of each air pollutant and stratified by underlying disorders. (B) RRs and 95% Cls for an IQR increment of cach air pollutant stratified by sex and age group (\<40, 40-59, ≥60). PM~10~, particulate matter less than 10 μm in aerodynamic diameter; NO~2~, introgen dioxide; SO~2~, sulfur dioxide; CO, carbon monoxide; O~3~, ozone; HD, hypertensive disease; IHD, ischemic heart disease; COPD, chronic obstructive pulmonary disease.](jpmph-51-6-265f1){#f1-jpmph-51-6-265}

###### 

General characteristics of ED visits for diabetic coma from 2005 to 2009 in Seoul, Korea

  Variable                  n (%)
  ------------------------- --------------
  Total                     3527 (100.0)
  Sex                       
   Male                     1788 (50.7)
   Female                   1739 (49.3)
  Age (y)                   
   \<40                     258 (7.3)
   40-59                    705 (20.0)
   ≥60                      2564 (72.7)
  Insurance status          
   Medical care             563 (16.0)
   Medical insurance        2964 (84.0)
  Underlying disease        
   Hypertensive disorder    1512 (42.9)
   Cardiovascular disease   249 (7.1)
   COPD                     197 (5.6)
   Asthma                   144 (4.1)
  Season                    
   Spring (Mar-May)         919 (26.1)
   Summer (Jun-Aug)         871 (24.7)
   Autumn (Sep-Nov)         881 (25.0)
   Winter (Dec-Feb)         856 (24.3)

ED, emergency department; COPD, chronic obstructive pulmonary disease.

###### 

Average air pollutant concentrations from 2005 to 2009 in Seoul, Korea

  Variable           Mean±SD       Percentile   IQR                             
  ------------------ ------------- ------------ ------- ------- ------- ------- -------
  PM~10~ (μg/m^3^)   57.10±38.81   23.20        34.80   49.81   70.47   98.51   35.67
  NO~2~ (ppb)        35.95±12.73   20.73        26.20   34.24   44.63   53.38   18.42
  SO~2~ (ppb)        5.66±2.51     3.30         3.87    4.94    6.74    9.03    2.87
  CO (ppm)           0.60±0.25     0.35         0.42    0.53    0.70    0.96    0.28
  O~3~ (ppb)         18.12±9.89    5.79         10.25   17.11   24.95   31.41   14.70
  Temperature (°C)   12.87±10.16   -1.50        4.16    14.51   21.89   25.14   17.73
  Humidity (%)       60.81±14.67   41.42        49.79   61.60   71.33   79.63   21.54

SD, standard deviation; IQR, interquartile range; PM~10~, particulate matter less than 10 μm in aerodynamic diameter; NO~2~, nitrogen dioxide; SO~2~, sulfur dioxide; CO, carbon monoxide; O~3~, ozone; ppb, parts per billion; ppm, parts per million.

###### 

Total RR and 95% CI for an IQR increment of each air pollutant, stratified by underlying diseases at cumulative lag 0-3

  Underlying disease                                                     Lag                                                                                                                                       
  ---------------------------------------------------------------------- ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- ----------------------
  Total                                                                                                                                                                                                            
   PM~10~                                                                0.998 (0.961, 1.037)   1.016 (0.975, 1.059)   0.973 (0.928, 1.020)   0.976 (0.936, 1.019)   1.014 (0.972, 1.059)   0.987 (0.938, 1.038)   0.963 (0.916, 1.014)
   NO~2~                                                                 0.995 (0.923, 1.073)   1.125 (1.039, 1.219)   0.975 (0.901, 1.055)   1.000 (0.933, 1.072)   1.120 (1.028, 1.219)   1.092 (0.998, 1.194)   1.092 (1.005, 1.186)
   SO~2~                                                                 1.026 (0.959, 1.098)   1.015 (0.941, 1.095)   0.992 (0.920, 1.069)   1.000 (0.940, 1.064)   1.042 (0.972, 1.117)   1.033 (0.961, 1.111)   1.033 (0.969, 1.101)
   CO                                                                    0.981 (0.919, 1.048)   1.106 (1.026, 1.194)   0.957 (0.887, 1.033)   1.003 (0.942, 1.068)   1.085 (1.011, 1.166)   1.039 (0.966, 1.116)   1.042 (0.980, 1.108)
   O~3~                                                                  1.009 (0.932, 1.092)   0.963 (0.886, 1.047)   1.001 (0.922, 1.087)   1.005 (0.931, 1.084)   0.972 (0.889, 1.063)   0.973 (0.887, 1.068)   0.978 (0.902, 1.060)
  Without past history^[1](#tfn1-jpmph-51-6-265){ref-type="table-fn"}^                                                                                                                                             
   PM~10~                                                                1.002 (0.952, 1.055)   0.990 (0.927, 1.057)   0.960 (0.892, 1.033)   0.961 (0.902, 1.024)   0.992 (0.929, 1.059)   0.952 (0.884, 1.026)   0.915 (0.850, 0.986)
   NO~2~                                                                 0.983 (0.883, 1.095)   1.164 (1.039, 1.305)   0.894 (0.799, 1.000)   1.038 (0.941, 1.145)   1.145 (1.014, 1.293)   1.023 (0.901, 1.161)   1.062 (0.944, 1.195)
   SO~2~                                                                 1.047 (0.951, 1.153)   0.964 (0.864, 1.076)   0.971 (0.870, 1.083)   0.981 (0.897, 1.073)   1.010 (0.913, 1.116)   0.980 (0.882, 1.089)   0.962 (0.876, 1.055)
   CO                                                                    0.982 (0.893, 1.080)   1.086 (0.973, 1.211)   0.912 (0.817, 1.018)   0.996 (0.911, 1.089)   1.067 (0.962, 1.182)   0.973 (0.876, 1.080)   0.969 (0.886, 1.059)
   O~3~                                                                  1.022 (0.914, 1.143)   0.967 (0.860, 1.088)   1.066 (0.949, 1.198)   0.919 (0.824, 1.024)   0.988 (0.870, 1.121)   1.054 (0.924, 1.201)   0.968 (0.863, 1.085)
  Hypertensive disease                                                                                                                                                                                             
   PM~10~                                                                0.987 (0.927, 1.051)   1.026 (0.968, 1.087)   0.988 (0.927, 1.053)   0.996 (0.940, 1.056)   1.013 (0.951, 1.078)   1.000 (0.926, 1.081)   0.997 (0.918, 1.082)
   NO~2~                                                                 1.010 (0.907, 1.126)   1.074 (0.948, 1.218)   1.076 (0.952, 1.216)   0.983 (0.887, 1.091)   1.086 (0.957, 1.232)   1.168 (1.014, 1.346)   1.149 (0.996, 1.325)
   SO~2~                                                                 1.004 (0.912, 1.106)   1.049 (0.937, 1.176)   1.015 (0.907, 1.137)   1.032 (0.941, 1.132)   1.054 (0.952, 1.167)   1.070 (0.957, 1.197)   1.104 (0.992, 1.229)
   CO                                                                    0.985 (0.897, 1.080)   1.118 (0.996, 1.255)   1.008 (0.899, 1.131)   1.018 (0.929, 1.115)   1.101 (0.995, 1.218)   1.110 (0.997, 1.236)   1.130 (1.026, 1.243)
   O~3~                                                                  0.968 (0.859, 1.090)   0.958 (0.842, 1.090)   0.944 (0.830, 1.072)   1.086 (0.969, 1.219)   0.927 (0.810, 1.060)   0.875 (0.758, 1.009)   0.950 (0.841, 1.074)
  Ischemic heart disease                                                                                                                                                                                           
   PM~10~                                                                1.058 (0.948, 1.181)   1.088 (0.993, 1.191)   1.031 (0.915, 1.161)   0.921 (0.782, 1.084)   1.151 (1.035, 1.279)   1.186 (1.022, 1.377)   1.092 (0.907, 1.315)
   NO~2~                                                                 1.027 (0.796, 1.325)   1.296 (0.962, 1.747)   1.031 (0.769, 1.384)   1.006 (0.785, 1.289)   1.332 (0.992, 1.788)   1.374 (0.990, 1.906)   1.382 (0.997, 1.915)
   SO~2~                                                                 0.860 (0.686, 1.079)   1.459 (1.137, 1.873)   0.961 (0.737, 1.253)   0.860 (0.686, 1.079)   1.256 (1.003, 1.571)   1.206 (0.934, 1.557)   1.084 (0.847, 1.387)
   CO                                                                    0.977 (0.786, 1.213)   1.372 (1.045, 1.803)   0.914 (0.693, 1.207)   0.976 (0.784, 1.216)   1.340 (1.060, 1.694)   1.226 (0.953, 1.576)   1.197 (0.960, 1.492)
   O~3~                                                                  1.287 (0.980, 1.689)   0.813 (0.599, 1.102)   0.936 (0.695, 1.261)   0.992 (0.758, 1.298)   1.046 (0.766, 1.427)   0.979 (0.703, 1.364)   0.971 (0.727, 1.296)
  COPD                                                                                                                                                                                                             
   PM~10~                                                                0.994 (0.861, 1.146)   0.993 (0.832, 1.185)   0.933 (0.751, 1.160)   0.924 (0.759, 1.125)   0.986 (0.824, 1.181)   0.920 (0.732, 1.156)   0.850 (0.668, 1.081)
   NO~2~                                                                 1.385 (1.031, 1.862)   0.915 (0.651, 1.286)   1.088 (0.784, 1.509)   1.006 (0.761, 1.329)   1.268 (0.910, 1.766)   1.379 (0.949, 2.002)   1.387 (0.950, 2.025)
   SO~2~                                                                 1.113 (0.864, 1.435)   0.966 (0.710, 1.315)   0.940 (0.689, 1.282)   1.149 (0.899, 1.468)   1.076 (0.817, 1.416)   1.011 (0.746, 1.371)   1.162 (0.870, 1.551)
   CO                                                                    1.153 (0.892, 1.489)   0.891 (0.648, 1.226)   1.075 (0.786, 1.471)   1.034 (0.802, 1.334)   1.028 (0.779, 1.356)   1.105 (0.821, 1.487)   1.143 (0.871, 1.498)
   O~3~                                                                  0.671 (0.479, 0.939)   1.132 (0.799, 1.604)   0.837 (0.591, 1.184)   1.113 (0.811, 1.526)   0.760 (0.524, 1.102)   0.636 (0.426, 0.948)   0.707 (0.500, 1.000)
  Asthma                                                                                                                                                                                                           
   PM~10~                                                                0.864 (0.677, 1.103)   1.162 (1.004, 1.345)   0.909 (0.723, 1.144)   0.977 (0.789, 1.211)   1.004 (0.829, 1.217)   0.913 (0.689, 1.211)   0.893 (0.672, 1.186)
   NO~2~                                                                 1.146 (0.817, 1.607)   1.096 (0.741, 1.622)   0.866 (0.595, 1.259)   1.222 (0.892, 1.674)   1.256 (0.854, 1.846)   1.087 (0.710, 1.666)   1.329 (0.864, 2.044)
   SO~2~                                                                 1.110 (0.823, 1.496)   0.986 (0.687, 1.414)   0.916 (0.636, 1.318)   1.221 (0.920, 1.620)   1.094 (0.793, 1.508)   1.001 (0.702, 1.429)   1.222 (0.877, 1.705)
   CO                                                                    0.912 (0.676, 1.232)   1.235 (0.857, 1.781)   0.852 (0.591, 1.228)   1.163 (0.874, 1.546)   1.127 (0.817, 1.555)   0.960 (0.680, 1.355)   1.116 (0.823, 1.515)
   O~3~                                                                  1.042 (0.725, 1.498)   0.886 (0.595, 1.318)   1.195 (0.811, 1.762)   0.868 (0.606, 1.243)   0.923 (0.614, 1.386)   1.103 (0.719, 1.694)   0.958 (0.663, 1.383)

RR, relative risk; CI, confidence interval; IQR, interquartile range; PM~10~, particulate matter less than 10 μm in aerodynamic diameter; NO~2~, nitrogen dioxide; SO~2~, sulfur dioxide; CO, carbon monoxide; O~3~, ozone; COPD, chronic obstructive pulmonary disease.

Past history includes hypertensive disease, ischemic heart disease, COPD, and asthma.

###### 

RR and 95% CI for an IQR increment of each air pollutant, stratified by sex and age group at cumulative lag 0-3

            Lag                                                                                                                                                         
  --------- -------- -------- ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- ----------------------
  Sex                                                                                                                                                                   
            Male                                                                                                                                                        
                     PM~10~   1.008 (0.957, 1.061)   1.008 (0.951, 1.069)   0.996 (0.935, 1.061)   0.951 (0.894, 1.012)   1.016 (0.957, 1.078)   1.012 (0.944, 1.084)   0.962 (0.896, 1.034)
                     NO~2~    0.983 (0.884, 1.093)   1.136 (1.015, 1.271)   0.972 (0.869, 1.087)   0.964 (0.874, 1.065)   1.116 (0.990, 1.259)   1.085 (0.956, 1.231)   1.046 (0.931, 1.176)
                     SO~2~    1.006 (0.915, 1.106)   1.016 (0.913, 1.130)   1.029 (0.926, 1.143)   0.956 (0.875, 1.044)   1.022 (0.927, 1.127)   1.052 (0.950, 1.165)   1.005 (0.919, 1.100)
                     CO       0.997 (0.909, 1.094)   1.065 (0.957, 1.187)   0.982 (0.881, 1.095)   0.966 (0.883, 1.055)   1.062 (0.961, 1.175)   1.043 (0.942, 1.156)   1.007 (0.924, 1.099)
                     O~3~     1.004 (0.898, 1.122)   0.989 (0.880, 1.112)   1.006 (0.896, 1.129)   1.028 (0.924, 1.144)   0.993 (0.876, 1.126)   0.999 (0.877, 1.138)   1.027 (0.918, 1.149)
            Female                                                                                                                                                      
                     PM~10~   0.988 (0.934, 1.044)   1.025 (0.966, 1.088)   0.948 (0.884, 1.017)   1.002 (0.946, 1.061)   1.013 (0.953, 1.076)   0.960 (0.892, 1.034)   0.962 (0.896, 1.034)
                     NO~2~    1.010 (0.908, 1.123)   1.116 (0.997, 1.250)   0.987 (0.883, 1.103)   1.032 (0.935, 1.138)   1.128 (1.000, 1.272)   1.113 (0.981, 1.263)   1.149 (1.022, 1.291)
                     SO~2~    1.049 (0.954, 1.154)   1.021 (0.917, 1.136)   0.954 (0.857, 1.062)   1.047 (0.960, 1.142)   1.071 (0.971, 1.181)   1.022 (0.922, 1.133)   1.070 (0.978, 1.171)
                     CO       0.969 (0.884, 1.062)   1.151 (1.035, 1.279)   0.939 (0.845, 1.045)   1.037 (0.950, 1.131)   1.115 (1.008, 1.232)   1.047 (0.946, 1.159)   1.086 (0.996, 1.184)
                     O~3~     1.023 (0.916, 1.144)   0.925 (0.823, 1.041)   0.993 (0.884, 1.116)   0.986 (0.886, 1.099)   0.947 (0.835, 1.074)   0.941 (0.825, 1.073)   0.928 (0.828, 1.040)
  Age (y)                                                                                                                                                               
            \<40                                                                                                                                                        
                     PM~10~   1.011 (0.884, 1.157)   1.030 (0.880, 1.207)   0.887 (0.725, 1.085)   1.025 (0.881, 1.194)   1.042 (0.886, 1.225)   0.924 (0.756, 1.129)   0.948 (0.784, 1.145)
                     NO~2~    0.934 (0.710, 1.229)   1.168 (0.881, 1.548)   0.951 (0.720, 1.256)   1.089 (0.853, 1.391)   1.091 (0.805, 1.479)   1.037 (0.750, 1.434)   1.130 (0.836, 1.526)
                     SO~2~    1.002 (0.779, 1.289)   1.082 (0.822, 1.422)   0.925 (0.704, 1.217)   0.966 (0.773, 1.207)   1.084 (0.840, 1.399)   1.003 (0.768, 1.310)   0.969 (0.765, 1.227)
                     CO       0.979 (0.766, 1.252)   1.094 (0.828, 1.447)   0.933 (0.709, 1.228)   0.993 (0.795, 1.240)   1.071 (0.826, 1.391)   1.000 (0.766, 1.306)   0.993 (0.789, 1.250)
                     O~3~     1.081 (0.817, 1.432)   1.013 (0.754, 1.360)   0.930 (0.692, 1.249)   0.936 (0.714, 1.228)   1.095 (0.798, 1.503)   1.018 (0.731, 1.418)   0.953 (0.714, 1.274)
            40-59                                                                                                                                                       
                     PM~10~   0.983 (0.899, 1.074)   1.017 (0.924, 1.120)   0.987 (0.890, 1.094)   0.968 (0.879, 1.067)   1.000 (0.907, 1.102)   0.987 (0.882, 1.105)   0.956 (0.852, 1.072)
                     NO~2~    0.985 (0.832, 1.167)   1.175 (0.981, 1.407)   0.949 (0.794, 1.135)   0.965 (0.824, 1.129)   1.158 (0.956, 1.403)   1.099 (0.899, 1.345)   1.060 (0.880, 1.277)
                     SO~2~    0.945 (0.811, 1.102)   1.048 (0.883, 1.244)   0.976 (0.823, 1.156)   1.045 (0.909, 1.200)   0.991 (0.846, 1.161)   0.967 (0.819, 1.143)   1.011 (0.874, 1.169)
                     CO       0.951 (0.821, 1.103)   1.123 (0.948, 1.332)   0.973 (0.819, 1.156)   1.016 (0.882, 1.170)   1.069 (0.911, 1.254)   1.041 (0.883, 1.225)   1.057 (0.919, 1.215)
                     O~3~     0.870 (0.728, 1.039)   0.939 (0.780, 1.131)   1.042 (0.868, 1.251)   1.090 (0.921, 1.290)   0.816 (0.669, 0.997)   0.851 (0.692, 1.047)   0.928 (0.776, 1.109)
            ≥60                                                                                                                                                         
                     PM~10~   1.007 (0.964, 1.051)   1.015 (0.967, 1.065)   0.978 (0.927, 1.033)   0.979 (0.932, 1.028)   1.021 (0.972, 1.073)   0.999 (0.942, 1.059)   0.978 (0.922, 1.038)
                     NO~2~    1.004 (0.919, 1.096)   1.108 (1.009, 1.218)   0.987 (0.900, 1.083)   1.002 (0.923, 1.088)   1.112 (1.006, 1.230)   1.098 (0.988, 1.220)   1.100 (0.999, 1.213)
                     SO~2~    1.054 (0.974, 1.140)   1.000 (0.915, 1.094)   1.002 (0.917, 1.095)   0.992 (0.922, 1.067)   1.054 (0.972, 1.143)   1.057 (0.971, 1.150)   1.048 (0.973, 1.129)
                     CO       0.991 (0.918, 1.070)   1.103 (1.009, 1.205)   0.958 (0.876, 1.048)   1.003 (0.932, 1.079)   1.093 (1.005, 1.188)   1.047 (0.962, 1.139)   1.050 (0.977, 1.128)
                     O~3~     1.042 (0.949, 1.144)   0.960 (0.871, 1.059)   0.988 (0.896, 1.089)   0.980 (0.896, 1.072)   1.001 (0.901, 1.112)   0.989 (0.886, 1.103)   0.969 (0.881, 1.066)

RR, relative risk; CI, confidence interval; IQR, interquartile range; PM~10~, particulate matter less than 10 μm in aerodynamic diameter; NO~2~, nitrogen dioxide; SO~2~, sulfur dioxide; CO, carbon monoxide; O~3~, ozone.
